PharmaDD Top News: Business, Technology, Strategic Briefings - Tracking leading techniques and approaches in therapeutic drug discovery and development

 

Sponsored Links:
Prescription Drug Addiction

 

 

Pharmaceutical Discovery, Oct 1, 2005 
Immobilization of Oligonucleotides on a Silicon Surface
By Patrizia Di Pietro , Enrico Alessi , Floriana San Biagio , Luigi La Magna , Gaetano Panvini , Gianfilippo Scicolone , Salvatore Oliveri , Salvo Coffa

A Nanofluidic Chip for Absolute Quantification of Target Nucleic Acid Sequences
Pharmaceutical Discovery

Fluidigm has developed a novel nanofluidic chip that provides reliable single-copy sensitivity and absolute quantification of target nucleic acid sequences. The Digital Isolation and Detection (DID) chip works by partitioning a sample/assay (TaqMan® assays) mixture into hundreds to tens of thousands of reaction chambers, where real-time QPCR reactions are continuously monitored by our Dynamic Array Reader. Only those chambers containing copies of target sequence produce signal, making it possible to calculate copy number in the entire sample extremely accurately. This note describes experiments using a DID chip to quantify TIMP-3 transcript and relates results to those from the dynamic array described in the preceding application note.

Introduction

When first developed, PCR was semi-quantitative at best. Advancements, such as exogenous competitive sequences, improved quantification accuracy and precision, and now real-time PCR (RT PCR) has become the technique of choice for sequence detection and quantification. Now, RT PCR can routinely achieve 2-fold discrimination when sufficient replicate reactions are run to provide statistical confidence. Despite these advancements, reliable single-copy detection and absolute quantification remain unmet needs. DID chips enable scientists to easily and quickly determine absolute copy number of nucleic acid sequences down to a single copy.

Experimental Conditions

 

Figure 1. DID chip. The DID chip consists of a carrier and an integrated fluidic circuit (IFC) center. The carrier contains 12 sample/reagent inputs, each of which holds a volume of 7.5 µL. The IFC partitions each mixture into 1,200 isolated reaction chambers.
Fluidigm has developed DID architectures with differing numbers of sample/assay inputs and densities of reactions per input. The DID chip described here (Figure 1) contains inputs for 12 sample/assay mixtures, and its architecture partitions 7.5 µL of fluid for each input into 1,200 reaction chambers.

Our instrumentation was used to drive the sample/assay mixtures from the wells in the carrier into the appropriate reaction chambers. Sample/assay mixtures consisted of a serial 5-fold dilution of Random-primed BD™ qPCR Human Reference cDNA (BD Biosciences) already mixed with TaqMan® Universal PCR Master Mix (Applied Biosystems), TIMP-3 primers and Black Hole Quencher™ DNA probe (IDT). The mixtures consisted of the following cDNA amounts: 5 pg, 1 pg, 1 pg, 200 fg, 200 fg, 40 fg, 40 fg, 8 fg, 8 fg, 1.6 fg, 1.6 fg, and no cDNA. Reaction- and thermal-cycling conditions were as described for TIMP-3 in the preceding note. Our dynamic array reader was used to perform thermal cycling, imaging, and data collection and our proprietary software was used for quantitative analysis.

Results

 

Figure 2. Absolute quantification of TIMP-3 transcript on a DID chip. The image shown is for FAM (excitation 485 nm; emission 525 nm) after 37 cycles of PCR. RT PCR data for each partition is available but not shown. The white spots indicate the presence of TIMP-3 transcript.
As shown in Figure 2, white spots indicate the location of reaction chambers positive for TIMP-3. The sum of TIMP-3 positive wells in each section is consistent with the TIMP-3 cDNA copies that were measured in the 5 pg, 1 pg, and 200 fg cDNA loads, at approximately 1 copy per 16 fg cDNA. This consistency demonstrates that single-copy detection in the DID chip is extremely reproducible and reliable. The cDNA loads of 40 fg and below showed less consistency due to sampling error.

The TIMP-3 concentration obtained from the DID chip was used to calculate an absolute TIMP-3 copy number in the dynamic array experiment (see Table 1 in our previous application note). The dynamic array yielded 9 of 16 positives (a digital response) for dilutions containing 7.2 fg per reaction chamber of cDNA, consistent with results from the DID experiment.

Conclusions

The DID chip enables absolute quantification of specific nucleic acid sequences. Furthermore, DID chips generate results that, if combined with results obtain from dynamic arrays, provide unmatched quantification accuracy while dramatically improving throughput and lowering cost. Because of their accuracy, DID chips provide a unique capability to detect rare sequences in the presence of a high background of similar sequences, often a requirement for the early detection of cancer.

1. The Dynamic Array Reader is instrumentation developed by Fluidigm to read fluorescent signal on its nanofluidic chips.

2. The chip-loading instrumentation was first developed by Fluidigm as the FID Crystallizer, part of the TOPAZ™ system for protein crystallization.

Fluidigm and TOPAZ are trademarks or registered trademarks of Fluidigm Corporation. All other trademarks are the property of their respective owners.